Substance Abuse Treatment Advisory: The Role of Biomarkers in the Treatment of Alcohol Use Disorders

This Advisory presents current information on biomarkers, which are physiological measurements that can indicate alcohol exposure or consumption.

It discusses the use and role of biomarkers in treatment, their limitations, and the pros and cons of each biomarker, and presents information on well-known markers, including the liver enzymes and mean corpuscular volume. Newer markers, such as carbohydrate-deficient transferrin (CDT) and phosphatidyl ethanol (PEth), are also discussed.

When used in conjunction with patient interviews and screening tools, these measures can provide valuable information about a patient's alcohol use.

Read the PDF of The Role of Biomarkers in the Treatment of Alcohol Use Disorders or click the link below to order:

http://ncadistore.samhsa.gov/catalog/productDetails.aspx?ProductID=17559

Publication Year: 2006

Publisher

SAMHSA's National Clearinghouse on Alcohol and Drug Information (NCADI)
11420 Rockville Pike
Rockville, md 20852
Phone: 800-729-6686
Website: http://www.ncadi.samhsa.gov